ANKRD46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.331000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.872400E-01
Normal-vs-Stage2
3.850600E-01
Normal-vs-Stage3
4.283900E-03
Normal-vs-Stage4
9.854200E-01
Stage1-vs-Stage2
3.186200E-02
Stage1-vs-Stage3
3.379900E-02
Stage1-vs-Stage4
6.451600E-01
Stage2-vs-Stage3
9.035800E-04
Stage2-vs-Stage4
3.098400E-01
Stage3-vs-Stage4
2.453800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.626800E-01
Normal-vs-AfricanAmerican
1.978560E-01
Normal-vs-Asian
3.154800E-01
Caucasian-vs-AfricanAmerican
6.864400E-01
Caucasian-vs-Asian
3.769800E-01
AfricanAmerican-vs-Asian
3.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.603400E-01
Normal-vs-Female
6.957000E-01
Male-vs-Female
9.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.480400E-01
Normal-vs-Age(41-60Yrs)
8.923000E-01
Normal-vs-Age(61-80Yrs)
6.927600E-01
Normal-vs-Age(81-100Yrs)
3.410200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.999000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.713200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.453600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.165200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.614400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.992600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.810400E-02
Normal-vs-Daily Drinker
5.089000E-01
Normal-vs-Weekly Drinker
6.812000E-02
Normal-vs-Occasional Drinker
8.867400E-01
Normal-vs-Social Drinker
7.853200E-01
Non Drinker-vs-Daily Drinker
7.599200E-01
Non Drinker-vs-Weekly Drinker
4.339200E-01
Non Drinker-vs-Occasional Drinker
1.470390E-01
Non Drinker-vs-Social Drinker
3.313800E-01
Daily Drinker-vs-Weekly Drinker
4.557000E-01
Daily Drinker-vs-Occasional Drinker
2.396200E-01
Daily Drinker-vs-Social Drinker
5.291800E-01
Weekly Drinker-vs-Occasional Drinker
9.461800E-02
Weekly Drinker-vs-Social Drinker
1.989150E-01
Occasional Drinker-vs-Social Drinker
5.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.048800E-01
Normal-vs-Grade 2
4.658000E-02
Normal-vs-Grade 3
7.866100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.960130E-02
Grade 1-vs-Grade 3
4.700000E-02
Grade 1-vs-Grade 4
2.048800E-01
Grade 2-vs-Grade 3
3.583600E-01
Grade 2-vs-Grade 4
4.658000E-02
Grade 3-vs-Grade 4
7.866100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.802800E-01
Normal-vs-NonDiabetic
7.287600E-01
Diabetic-vs-NonDiabetic
3.848200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.307960E-02
Normal-vs-NoPancreatitis
7.344400E-01
Pancreatitis-vs-NoPancreatitis
3.258900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.898600E-01
Normal-vs-N1
4.400000E-01
N0-vs-N1
1.794250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.868600E-01
Normal-vs-TP53-NonMutant
8.417000E-01
TP53-Mutant-vs-TP53-NonMutant
3.144100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
